| Matthew Grimes, | |
|
960 Century Dr, Mechanicsburg, PA 17055-4374 | |
| (717) 795-0330 | |
| Not Available |
| Full Name | Matthew Grimes |
|---|---|
| Gender | Male |
| Speciality | Counselor |
| Location | 960 Century Dr, Mechanicsburg, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023329554 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Grimes, 1791 San Gabriel Dr, York, PA 17406-1814 Ph: () - | Matthew Grimes, 960 Century Dr, Mechanicsburg, PA 17055-4374 Ph: (717) 795-0330 |
News Archive
Data from the international, multi-center, open-label, two-part, single-arm Phase 2 MMY2002 (SIRIUS) trial show treatment with single-agent daratumumab – an investigational, human anti-CD38 monoclonal antibody – achieved an overall response rate (ORR) of 29.2 percent (95% CI, 20.8-38.9), as assessed by an independent review committee, in heavily pre-treated patients with multiple myeloma.
Syngene, a world-leading manufacturer of image analysis solutions, is delighted to announce its GeneSys software is now available with the addition of new ChemiRapid, Signal Accumulation Calculator and Enhanced Image features designed to improve chemiluminescence imaging workflow and quality.
Researchers Araceli Castelló-Martínez and Victoria Tur-Viñes, from the Department of Communication and Social Psychology at the University of Alicante (UA), warn about the advertising of ultra-processed food for children by the most followed YouTubers in the form of challenges, sweepstakes or pastimes.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that preliminary results from its ENABLE Phase 2 proof-of-concept trial demonstrated that bafetinib, the Company's Bcr-Abl, Lyn and Fyn kinase inhibitor, was clinically active in a group of patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL) who have failed several other treatments for their cancer.
Mortality rates from pulmonary fibrosis (PF) have increased significantly in recent years, and are predicted to continue to rise, according to researchers from the University of Colorado.
› Verified 2 days ago
Cheryl Cotton, Counselor Medicare: Not Enrolled in Medicare Practice Location: 960 Century Dr, Diakon Family Life Services, Mechanicsburg, PA 17055 Phone: 717-795-0330 | |
Brooke Serina, MA, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 411 E Main St, Mechanicsburg, PA 17055 Phone: 717-610-2988 | |
Stephanie M. Hallett, MSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 960 Century Dr, Mechanicsburg, PA 17055 Phone: 717-795-0330 Fax: 717-795-0407 | |
Justin Smith, Counselor Medicare: Not Enrolled in Medicare Practice Location: 960 Century Dr, Diakon Fls, Mechanicsburg, PA 17055 Phone: 717-795-0330 | |
Mrs. Melanie Anne Eleanor Grem, L.S.W. Counselor Medicare: Not Enrolled in Medicare Practice Location: 960 Century Drive, Suite 102, Mechanicsburg, PA 17050 Phone: 717-795-0330 Fax: 717-795-0407 | |
Matthew Kimble, Counselor Medicare: Not Enrolled in Medicare Practice Location: 920 Century Dr, Mechanicsburg, PA 17055 Phone: 717-766-6974 |